- Biovail Corp.
- Cipher Pharmaceuticals Inc.
- Labopharm Inc.
- Purdue Pharma LP
- Johnson & Johnson
- Ortho-McNeil Inc.
- Ortho Pharmaceutical Corp.
- Actavis Laboratories
- Elan Corp. PLC
- Mylan NV
- Shire PLC
- Novartis AG
- Hexal AG
- Recordati Industria Chimica & Farmaceutica SPA
- CSC Pharmaceuticals Handels GMBH
- Ligand Pharmaceuticals Inc.
- Nicox SA
- Pain Therapeutics Inc.
- King Pharmaceuticals Inc.
- Purdue Pharma LP to distribute Labopharm's tramadol
- Ortho-McNeil will market Biovail's tramadol formulations
- J&J to co-develop, co-promote Purdue Frederick's tramadol
- Hexal gets rights to Labopharm's tramadol
- Grunenthal to sell Labopharm's pain drug in France
- Recordati to sell Labopharm's tramadol in the UK; ends
- CSC Pharmaceuticals to license Labopharm's tramadol
- Esteve, Angelini sell Labopharm's tramadol for pain
- King to sell Pain Therapeutics' abuse-resistant oxycodone; terminated
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.